Mega Investment
VC Fund
Seoul, South Korea
Mega Investment is a VC fund in Seoul focused on E-Commerce and Apps. Innovative and Passionate Value Creating Venture Capital
- Total investments:
- 32
- Last investment:
- Lead investor:
- 9%
Last updated:
For AI agents: llms.txt
Industries Mega Investment invests in
Stages Mega Investment invests in
Countries Mega Investment invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Series A
- $1.4M–$5.9M
- Series B
- $3.7M–$27M
Investment Focus
Industry
- E-Commerce 5 (16%)
- Apps 4 (13%)
- Biotechnology 4 (13%)
- Logistics 3 (9%)
- Health Care 3 (9%)
Stage
- Series A 15 (47%)
- Series B 9 (28%)
- Funding Round 5 (16%)
- Seed 3 (9%)
Country
- South Korea 24 (75%)
- India 1 (3%)
- Pakistan 1 (3%)
- United States 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Dong-Hoon Kim
Executive Director
|
Executive Director | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Robo Arete
|
Robo Arete is a completely automated and robotics enables F&B servicing company with restaurants and takeaways. | $5.8M / Series A / May 12, 2022 | |
Balaan
|
Balaan is a platform that allows you to get the latest luxury goods in just 3 days at a lower price than overseas fasting by contract with European local boutique | $27.3M / Series B / Oct 07, 2021 | |
Modern Toy
|
Modern Toy is a character toy developing company that manufactures and distributes toys for infants, girls, and boys. | $3.3M / Series A / Oct 06, 2021 | |
Dohands
|
Dohands provides customized logistics services. | $18.5M / Series B / Sep 08, 2021 | |
Wonderwall
|
Wonderwall is an online art learning platform. | $8.9M / Series B / May 20, 2021 | |
Novelty Nobility
|
Novelty Nobility Inc. is a private biotech company. They are currently focused on the research of novel angiogenesis targets and develop antibody-based therapeutics in ophthalmology and oncology, where angiogenesis plays a key pathogenic role.In ophthalmology, Novelty Nobility first discovered a novel angiogenesis target, Stem Cell Factor(SCF)and c-KIT, which was initially known for its engagement with proliferation and survival of primitive hematopoietic stem cells for a couple of past decades. We believe that anti-SCF/c-KIT could effectively address the unmet medical needs, mostly caused by inherent limitations of anti-VEGFs, in terms of treatment efficacy and long-term safety. Our target discovery is widely and strongly patent-protected in US/KOR and the lead pipeline, NN2101(a full-human monoclonal antibody), is currently under preclinical development. | $7.1M / Series B / Mar 05, 2021 | |
Play Tango
|
Play Tango develops interactive learning products that aim to change the way children learn. Tango is a screenless smartboard that senses, reads, and provides real-time feedback on tangible blocks. | $2.7M / Series A / Feb 10, 2021 | |
Inexoplat
|
INEXOPLAT operates as a biotechnology company focused on developing exosome-based cancer immunotherapy solutions. It works on converting cold tumors into immune-active tumors using proprietary biological platforms. The company also provides R&D outsourcing services including drug development support, CMC (Chemistry, Manufacturing and Controls),and regulatory consulting for biotech and pharmaceutical innovation. | $1.9M / Seed / Jan 01, 2021 | |
poled
|
Poled develops and manufactures car seat that has passed real vehicle crash tests. | $5.9M / Series A / Dec 28, 2020 | |
Autotelic Bio
|
Autotelic Bio is a bio technology company that researches and develops anti-cancer drugs. | $5.4M / Series A / Jul 01, 2020 | |
| See all 32 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Mega Investment invest in?
Mega Investment invests primarily in E-Commerce, Apps and Biotechnology startups, most often at Series A and Series B stage. Most of the 32 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Mega Investment's check size?
Mega Investment typically joins rounds of $1.4M–$5.9M at Series A and $3.7M–$27M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Mega Investment participates in.
How do I contact Mega Investment?
Public channels for Mega Investment include the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Mega Investment?
The team at Mega Investment includes Dong-Hoon Kim (Executive Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
